Exploiting Cancer Cells Metabolic Adaptability to Enhance Therapy Response in Cancer

Research output: Contribution to journalArticle


Despite all the progresses developed in prevention and new treatment approaches, cancer is the second leading cause of death worldwide, being chemoresistance a pivotal barrier in cancer management. Cancer cells present several mechanisms of drug resistance/tolerance and recently, growing evidence have been supporting a role of metabolism reprograming per se as a driver of chemoresistance. In fact, cancer cells display several adaptive mechanisms that allow the emergency of chemoresistance, revealing cancer as a disease that adapts and evolve along with the treatment. Therefore, clinical protocols that take into account the adaptive potential of cancer cells should be more effective than the current traditional standard protocols on the fighting against cancer.In here, some of the recent findings on the role of metabolism reprograming in cancer chemoresistance emergence will be discussed, as the potential evolutionary strategies that could unable these adaptations, hence allowing to prevent the emergency of treatment resistance, changing cancer outcome.

Original languageEnglish
Pages (from-to)297-310
Number of pages14
JournalAdvances in Experimental Medicine and Biology
Publication statusPublished - 2020


  • Adaptation
  • Cancer
  • Chemoresistance
  • Evolution
  • Metabolism

Fingerprint Dive into the research topics of 'Exploiting Cancer Cells Metabolic Adaptability to Enhance Therapy Response in Cancer'. Together they form a unique fingerprint.

Cite this